Advanced search
Publication Cover
Expert Review of Anti-infective Therapy Volume 10, 2012 - Issue 11
Submit an article Journal homepage
259
Views
10
CrossRef citations to date
0
Altmetric
Clinical Trial Report

The MOTIVATE trials: maraviroc therapy in antiretroviral treatment-experienced HIV-1-infected patients

Steven FL van Lelyveld Department of Internal Medicine and Infectious Diseases, University Medical Center Utrecht, Huispostnummer F.02.126, Postbus 85500, 3508 GA Utrecht, The Netherlands; Department of Internal Medicine and Infectious Diseases, University Medical Center Utrecht, Huispostnummer F.02.126, Postbus 85500, 3508 GA Utrecht, The Netherlands. [email protected]
,
Annemarie MJ Wensing Department of Virology, Medical Microbiology, University Medical Center Utrecht, Huispostnummer F.02.126, Postbus 85500, 3508 GA Utrecht, The Netherlands; Department of Virology, Medical Microbiology, University Medical Center Utrecht, Huispostnummer F.02.126, Postbus 85500, 3508 GA Utrecht, The Netherlands
&
Andy IM Hoepelman Department of Internal Medicine and Infectious Diseases, University Medical Center Utrecht, Huispostnummer F.02.126, Postbus 85500, 3508 GA Utrecht, The Netherlands; Department of Internal Medicine and Infectious Diseases, University Medical Center Utrecht, Huispostnummer F.02.126, Postbus 85500, 3508 GA Utrecht, The Netherlands
Pages 1241-1247 | Published online: 10 Jan 2014

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Michelle B. Kim, Kyle E. Giesler, Yesim A. Tahirovic, Valarie M. Truax, Dennis C. Liotta & Lawrence J. Wilson. (2016) CCR5 receptor antagonists in preclinical to phase II clinical development for treatment of HIV. Expert Opinion on Investigational Drugs 25:12, pages 1377-1392.
Read now

Articles from other publishers (9)

Ronald Rose, Margaret Gartland, Zhufang Li, Nannan Zhou, Mark Cockett, Jagadish Beloor, Max Lataillade, Peter Ackerman & Mark Krystal. (2022) Clinical evidence for a lack of cross-resistance between temsavir and ibalizumab or maraviroc. AIDS 36:1, pages 11-18.
Crossref
María Rosa López-Huertas, Laura Jiménez-Tormo, Nadia Madrid-Elena, Carolina Gutiérrez, María Jesús Vivancos, Laura Luna & Santiago Moreno. (2020) Maraviroc reactivates HIV with potency similar to that of other latency reversing drugs without inducing toxicity in CD8 T cells. Biochemical Pharmacology 182, pages 114231.
Crossref
M. Ghannad, M. Dennehy, C. la Porte, I. Seguin, D. Tardiff, R. Mallick, E. Sabri, G. Zhang, S. Kanji & D. W. Cameron. (2019) A drug interaction study investigating the effect of Rifabutin on the pharmacokinetics of Maraviroc in healthy subjects. PLOS ONE 14:10, pages e0223969.
Crossref
Tianwen Li & Jianhong Zhu. (2019) Entanglement of CCR5 and Alzheimer’s Disease. Frontiers in Aging Neuroscience 11.
Crossref
Sulemon Chaudhry, Jean Emond & Adam Griesemer. (2019) Immune Cell Trafficking to the Liver. Transplantation 103:7, pages 1323-1337.
Crossref
Sanjay Pujari, Sunil Gaikwad, Vivek Bele, Kedar Joshi & Digamber Dabhade. (2018) High Virologic Failure Rates with Maraviroc-Based Salvage Regimens Among Indian Patients: A Preliminary Analysis—Maraviroc Effectiveness in HIV-1 Subtype C. Journal of the International Association of Providers of AIDS Care (JIAPAC) 17, pages 232595821875921.
Crossref
Jacqueline K. FlynnPaula EllenbergRenee DuncanAnne EllettJingling ZhouJasminka SterjovskiKieran CashinKatharina BormLachlan R GrayMarilyn LewisBecky JubbMike WestbyBenhur LeeSharon R LewinMelissa ChurchillMichael RochePaul R. Gorry. (2017) Analysis of Clinical HIV-1 Strains with Resistance to Maraviroc Reveals Strain-Specific Resistance Mutations, Variable Degrees of Resistance, and Minimal Cross-Resistance to Other CCR5 Antagonists. AIDS Research and Human Retroviruses 33:12, pages 1220-1235.
Crossref
Claudia MontagnaElisa De CrignisIsabella BonMaria Carla ReIvano MezzaromaOmbretta TurrizianiCecilia GraziosiGuido Antonelli. (2014) V3 Net Charge: Additional Tool in HIV-1 Tropism Prediction. AIDS Research and Human Retroviruses 30:12, pages 1203-1212.
Crossref
Isobel D. Ramsay, Jodi M. Lestner, Catherine P. O’Sullivan, Ana L.G. Cruz, Ho Kwong Li & Charlotte I.S. Barker. 2014. A worldwide yearly survey of new data in adverse drug reactions. A worldwide yearly survey of new data in adverse drug reactions 401 443 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.